PCV61 are Hospital Costs for Stroke Underestimated in Spain?
M.Á. Casado(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), N. Gonzalez Rojas(Boehringer Ingelheim (Spain)), Juan Oliva(University of Castilla-La Mancha), Jaime Masjuán(Universidad de Alcalá), Javier Mar(Hospital Alto Deba), Virginia Becerra(Boehringer Ingelheim (Spain)), M. Yébenes(Pharmacoeconomics and Health Outcomes Research Iberia (Spain))
Cited by 3
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
|The Lancet|2012|280
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
|Journal of Clinical Investigation|2005|257